Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2490181000168110 | Co-Enzyme Q10 (Bioglan) (ubidecarenone 100 mg) capsule, 30 capsules, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2490191000168113 | Co-Enzyme Q10 (Bioglan) 100 mg capsule, 30, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Co-Enzyme Q10 (Bioglan) 100 mg capsule, 30, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Co-Enzyme Q10 (Bioglan) 100 mg capsule, 30, bottle | Is a | Co-Enzyme Q10 (Bioglan) 100 mg capsule, 30 | true | Inferred relationship | Some | ||
| Co-Enzyme Q10 (Bioglan) 100 mg capsule, 30, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Co-Enzyme Q10 (Bioglan) 100 mg capsule, 30, bottle | has TP | Co-Enzyme Q10 (Bioglan) | true | Inferred relationship | Some | ||
| Co-Enzyme Q10 (Bioglan) 100 mg capsule, 30, bottle | has TPUU | Co-Enzyme Q10 (Bioglan) 100 mg capsule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR